Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly
ABT [NYSE]
Abbott Laboratories
Healthcare | Drug Manufacturers - Major | USA
financial highlights | statements
IndexS&P 500 P/E76.55 EPS (ttm)0.49 Insider Own0.20% Shs Outstand1.57B Perf Week1.85%
Market Cap58.84B Forward P/E16.70 EPS next Y2.25 Insider Trans14.24% Shs Float1.56B Perf Month2.51%
Income772.70M PEG6.37 EPS next Q0.44 Inst Own67.00% Short Float0.72% Perf Quarter12.27%
Sales21.59B P/S2.73 EPS this Y-88.10% Inst Trans-1.82% Short Ratio1.61 Perf Half Y20.84%
Book/sh14.40 P/B2.60 EPS next Y11.74% ROA9.00% Target Price40.72 Perf Year29.03%
Cash/sh5.43 P/C6.91 EPS next 5Y12.02% ROE20.90% 52W Range28.83 - 38.77 Perf YTD20.57%
Dividend0.56 P/FCF17.91 EPS past 5Y-31.00% ROI1.30% 52W High-4.49% Beta0.34
Dividend %1.49% Quick Ratio1.60 Sales past 5Y-3.70% Gross Margin55.20% 52W Low28.46% ATR0.73
Employees91000 Current Ratio1.80 Sales Q/Q1.80% Oper. Margin10.60% RSI (14)49.70 Volatility1.83% 1.99%
OptionableYes Debt/Eq0.31 EPS Q/Q54.50% Profit Margin24.40% Rel Volume0.59 Prev Close37.51
ShortableYes LT Debt/Eq0.15 EarningsApr 17 BMO Payout38.80% Avg Volume6.98M Price37.03
Recom2.50 SMA20-0.51% SMA500.25% SMA2009.96% Volume2,198,043 Change-1.28%
28-May-13Reiterated RBC Capital Mkts Outperform $38 → $42
21-May-13Initiated Gabelli & Co Buy
19-Apr-13Reiterated RBC Capital Mkts Outperform $37 → $38
18-Apr-13Reiterated Stifel Buy $40 → $44
12-Apr-13Reiterated Deutsche Bank Hold $33 → $35
15-Feb-13Initiated Stifel Nicolaus Buy $40
11-Jan-13Reiterated UBS Buy $75 → $38
11-Jan-13Initiated Barclays Equal Weight $35
04-Jan-13Downgrade Deutsche Bank Buy → Hold $70 → $33
19-Jul-12Reiterated UBS Buy $68 → $72
19-Mar-12Reiterated UBS Buy $62 → $68
19-Mar-12Reiterated RBC Capital Mkts Outperform $60 → $68
09-Dec-11Downgrade Barclays Capital Overweight → Equal Weight $55 → $55
27-Oct-11Reiterated Deutsche Bank Hold $53 → $58
24-Aug-11Downgrade Morgan Keegan Outperform → Mkt Perform $60 → $57
07-Apr-11Initiated Deutsche Bank Hold $53
24-Jan-11Reiterated Barclays Capital Overweight $60 → $55
18-Jan-11Downgrade RBC Capital Mkts Top Pick → Outperform $66 → $60
27-Oct-10Downgrade Argus Buy → Hold
12-Mar-10Downgrade Citigroup Hold → Sell $46 → $52
18-Jun-13 12:34PM  The Best Healthcare Bet at Motley Fool
10:13AM  Supreme Court Permits Antitrust Scrutiny Of Pharma Settlements at Forbes
17-Jun-13 05:44PM  Drugmakers Opened to Pay for Delay Suits by High Court at Bloomberg
04:12PM  Abbott Loves Abbott Laboratories Stock at Motley Fool
03:45PM  Successor To Humira? AbbVie And Galapagos Work On It at Seeking Alpha
03:45PM  Successor To Humira? Abbvie And Galapagos Work On It at Seeking Alpha
02:37PM  Can Cempra Beat The Superbugs? at Seeking Alpha
01:49PM  Supreme Court decision on generics hits Actavis, but few other drug firms at MarketWatch
01:03PM  5 Stocks Raising The Drugs Industry Higher at TheStreet
12:46PM  Supreme Court decision on generics hits Actavis, but few other drug firms at MarketWatch
11:59AM  Supreme Court Revives Actavis 'Pay For Delay' Case at Investor's Business Daily
10:20AM  Drugmakers Opened to Pay for Delay Suits by High Court at Bloomberg
15-Jun-13 03:52PM  Abbott Declares Dividend and $3 Billion Buyback Plan at Motley Fool
14-Jun-13 05:30PM  Abbott Progresses with Absorb in Japan Zacks
01:17PM  Daily Dividend Report: ABT, LHO, DX, AT, RLJ at Forbes
12:25PM  1 Huge Opportunity for the Star Stent of the Future at Motley Fool
12:23PM  InPlay: Abbott Labs Board authorizes repurchase of up to $3 billion of the co's common stock Briefing.com
12:22PM  Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend PR Newswire
09:54AM  Should You Buy This Dividend Aristocrat? at Motley Fool
13-Jun-13 06:59PM  As top court invalidates some gene patents, biotech has moved on at Reuters
04:34PM  These Companies Have a Formula for Success at Motley Fool
11:10AM  Despite Billions Of Dollars Saved, Congress Tries To Thwart Medicare's Competitive Bidding at Forbes
11:07AM  Identifying the Biggest Gem in Antares's Pipeline at Motley Fool
12-Jun-13 05:01PM  Abbott Laboratories (ABT): Today's Featured Health Services Laggard at TheStreet
01:21PM  [video] Dollar Index Hits 4-Month Low at CNBC
11:49AM  Abbott Labs' Absorb And The Dissolvable Stent Race at Seeking Alpha
10:50AM  Abbott Launches Japanese Stent Trial at Motley Fool
11-Jun-13 06:32PM  Abbott Laboratories' Management Discusses at William Blair Growth Stock Conference (Transcript) Seeking Alpha
01:04PM  5 Drugs Stocks Dragging The Industry Down at TheStreet
10:49AM  Cramer: Buy Costco, Abbott Labs, and AbbVie, But Sell Fortinet at Wall St. Cheat Sheet
09:30AM  InPlay: Abbott Labs initiates randomized clinical trial in Japan to evaluate the Absorb Bioresorbable Vascular Scaffold Briefing.com
09:30AM  Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb Bioresorbable Vascular Scaffold PR Newswire
07:02AM  Cramer's Lightning Round - Fortinet Is Impossible (6/10/13) at Seeking Alpha
06:20AM  [$$] How to Play the Biotech Boom at Barrons.com
10-Jun-13 07:43PM  'Mad Money' Lightning Round: The Bears Are Wrong on Hain at TheStreet
04:00PM  Abbott Doubled Niaspan U.S. Sales Before Trials Cut Use at Bloomberg
02:23PM  [video] Is Facebook the Most Compelling Stock Right Now? at MarketWatch
11:18AM  5 Rocket Stocks to Buy After Last Week's Bounce at TheStreet
08:30AM  Abbott to Present at Wells Fargo Securities Research & Economics 2013 Healthcare Conference PR Newswire
08-Jun-13 05:19AM  A Patient Pursuit at Barrons.com
06-Jun-13 02:34PM  Analysts: Abbott Labs EPS Will Grow and 3 More Research Notes to Explore at Wall St. Cheat Sheet
09:53AM  [video] Cramer's Six in 60: FHN, ABT & More at CNBC
05-Jun-13 05:01PM  Abbott Laboratories (ABT): Today's Featured Health Services Laggard at TheStreet
04:49PM  Abbott Board Must Face Depakote Investor Suit, Judge Says at Bloomberg
02:06PM  These 3 Drug Stocks May Cure Summertime Blues at Seeking Alpha
08:12AM  Biocon Seeks Partner to Sell Rival Drug to J&Js Stelara at Bloomberg
04-Jun-13 07:37PM  4 Healthcare Stock Stories Attracting Attention Today at Wall St. Cheat Sheet
03:57PM  InPlay: Abbott Labs: Two Real-World European Studies of Abbott's Minimally Invasive MitraClip Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation Briefing.com
03:56PM  Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation PR Newswire
10:34AM  Pepsi Helps In Muller Expansion, STMicroelectronics Eyes Ambitious Growth, and 3 More Hot Stocks at Wall St. Cheat Sheet
08:30AM  Abbott to Present at William Blair 33rd Annual Growth Stock Conference PR Newswire
07:40AM  [$$] Receptive to Receptos at Barrons.com
03:21AM  AstraZeneca Wont Seek Approval for Rigel Arthritis Drug at Bloomberg
03-Jun-13 11:47AM  The Big Business of Falling Asleep Big Data Download
11:47AM  The Big Business of Falling Asleep
31-May-13 04:53PM  Evaluating Johnson & Johnson's Economic Moat at Seeking Alpha
04:45PM  Abbott Labs' HPV Test in Canada Zacks
01:03PM  5 Health Services Stocks Dragging The Industry Down at TheStreet
09:04AM  Can Abbott Laboratories Maintain the Lead? at Wall St. Cheat Sheet
08:30AM  Abbott to Present at Goldman Sachs 34th Annual Global Healthcare Conference PR Newswire
29-May-13 10:10PM  Here's What This 758% Gainer Has Been Buying at Motley Fool
08:47PM  Abbott Laboratories' Management Presents at Deutsche Bank 38th Annual Health Care Conference (Transcript) Seeking Alpha
07:11AM  Why Abbott Labs Is Poised to Keep Poppin' at Motley Fool
07:00AM  Abbott Introduces its RealTime Molecular Test for Human Papillomavirus (HPV) in Canada CNW Group
28-May-13 02:00PM  Tuesday's Top Upgrades (and Downgrades) at Motley Fool
12:51PM  Bet Big on Boomers and Babies at Motley Fool
11:51AM  Sector Snap: Analysts expect pharma restructuring AP
11:15AM  3 Pharma Companies to Buy in 2013 at Motley Fool
04:30AM  Oasmia Rises on New Cancer Combination Drug: Stockholm Mover at Bloomberg
27-May-13 02:59AM  Heart device approval delays leave US doctors frustrated at Reuters
25-May-13 10:29AM  Obamacare Will Bring Drug Industry $35 Billion In Profits at Forbes
23-May-13 04:30PM  AbbVie Price Boost of Drug Slammed in Studies Criticized at Bloomberg
03:48PM  Follow The 'Smart Money' And Buy Johnson & Johnson In The Next Pullback at Seeking Alpha
11:20AM  Socially Minded Seniors Keep Co-Op Spirit Alive In Cambridge at Forbes
09:55AM  AbbVie Price Boost of Drug Slammed in Studies Criticized at Bloomberg
08:48AM  Abbott Laboratories: Undervalued Potential at Seeking Alpha
22-May-13 06:05PM  CE Mark for Abbott's Xience Xpedition 48 Zacks
03:20PM  A Moderate-Risk, High-Reward Dividend Play at Seeking Alpha
09:56AM  Abbott Laboratories' Management Presents at UBS Global Healthcare Conference (Transcript) Seeking Alpha
08:30AM  Abbott to Present at Deutsche Bank 38th Annual Health Care Conference PR Newswire
07:48AM  AbbVie Reaches New Highs Thanks To Humira at Seeking Alpha
01:23AM  AbbVie: Sliding Safely Instead Of Falling Off The Patent Cliff at Seeking Alpha
21-May-13 09:01PM  For U.S. Companies, Money Offshore Means Manhattan at New York Times
08:08AM  InPlay: Abbott Labs announces CE Mark for world's longest coronary drug eluting stent Briefing.com
08:00AM  Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent PR Newswire
02:23AM  Coverage initiated on Abbott Labs by Gabelli & Co Briefing.com
02:06AM  Johnson & Johnson Stock Checkup for May at Motley Fool
20-May-13 02:12PM  Analyst Moves: ABT, ACN, EFX, JCP at Forbes
01:48PM  Why This Stock Could Be a Smart Investment at Motley Fool
01:40PM  Analysts: Boeings Outlook Is Positive and 3 More Research Notes to Explore at Wall St. Cheat Sheet
01:24PM  July Options Now Available For Abbott Laboratories (ABT) at Forbes
01:03PM  5 Drugs Stocks On The Rise at TheStreet
11:48AM  Abbott gets some analyst love for diversifying, meeting generic threats at MarketWatch
11:34AM  Vodafones Options After Verizons Buyout and 3 Other Hot Stocks at Wall St. Cheat Sheet
10:50AM  Will Obamacare Crush Medtronic's Earnings? at Motley Fool
09:25AM  Stock Upgrades: Priceline Is Going Places at Minyanville
08:43AM  Analysts' Actions: ABT ACN GD KMX PCLN TheStreet
17-May-13 06:34PM  Abbott Laboratories Stock Checkup for May at Motley Fool
06:29PM  Jim Cramer's Down and Out Turnaround Play at CNBC
06:29PM  [video] Companies That Shine After Spinoffs at CNBC
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mason Heather LSenior Vice PresidentJun 07Sale37.0112,000444,178112,421Jun 11 05:29 PM
FREYMAN THOMAS CExecutive Vice PresidentApr 01Option Exercise22.2763,8001,420,635358,713Apr 03 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentMar 12Option Exercise25.5349,5641,265,313337,400Mar 14 05:10 PM
Warmuth Michael JExecutive Vice PresidentFeb 19Sale34.783,066106,64135,552Feb 20 06:19 PM
Mason Heather LSenior Vice PresidentFeb 19Sale34.793,066106,672194,172Feb 20 06:18 PM
Simhambhatla Murthy VSenior Vice PresidentFeb 19Sale34.7840213,98331,135Feb 20 06:18 PM
LINDER GREG WDirectorFeb 19Sale34.761,31445,679146,663Feb 20 05:35 PM
Landgraf John CExecutive Vice PresidentFeb 19Sale34.783,066106,641118,492Feb 20 05:34 PM
Fussell Stephen RSenior Vice PresidentFeb 19Sale34.803,066106,702112,558Feb 20 05:32 PM
Blaser Brian JExecutive Vice PresidentFeb 19Sale34.791,02235,558108,137Feb 20 05:18 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 19Sale34.794,672162,545354,149Feb 20 05:18 PM
Fussell Stephen RSenior Vice PresidentFeb 01Option Exercise31.909,690309,123104,783Feb 04 05:56 PM
OSBORN WILLIAM ADirectorFeb 01Buy33.8610,000338,55834,476Feb 04 05:55 PM
Fussell Stephen RSenior Vice PresidentFeb 01Sale33.899,690328,39495,093Feb 04 05:56 PM
WHITE MILES DChairman and CEOJan 14Option Exercise25.76346,7048,929,5351,569,971Jan 16 05:04 PM
Schumacher Laura JExecutive Vice PresidentDec 11Option Exercise50.14119,7776,006,037299,115Dec 13 05:14 PM
Schumacher Laura JExecutive Vice PresidentDec 11Sale66.00119,7777,905,282179,338Dec 13 05:14 PM
Forrest A. DavidSenior Vice PresidentDec 10Option Exercise50.5235,3351,785,20170,350Dec 12 05:12 PM
Forrest A. DavidSenior Vice PresidentDec 10Sale65.1047,2863,078,31923,064Dec 12 05:12 PM
Blaser Brian JExecutive Vice PresidentDec 06Option Exercise50.5264,1013,238,564143,825Dec 10 05:04 PM
Blaser Brian JExecutive Vice PresidentDec 06Sale64.5226,3541,700,36079,724Dec 10 05:05 PM
Blaser Brian JExecutive Vice PresidentDec 06Sale64.4537,7472,432,931106,078Dec 10 05:04 PM
Forrest A. DavidSenior Vice PresidentDec 06Sale64.5935222,73622,755Dec 21 02:45 PM
WHITE MILES DChairman and CEONov 02Option Exercise54.05513,31227,743,2731,753,068Nov 05 06:02 PM
WHITE MILES DChairman and CEONov 02Sale65.62122,4318,033,8601,256,913Nov 05 06:02 PM
WHITE MILES DChairman and CEONov 02Sale65.7917,1571,128,7601,239,756Nov 05 06:02 PM
WHITE MILES DChairman and CEONov 02Sale65.52373,72424,487,7961,379,344Nov 05 06:02 PM
Blaser Brian JExecutive Vice PresidentOct 25Sale65.764,000263,04279,724Oct 26 05:04 PM
Fussell Stephen RSenior Vice PresidentOct 24Option Exercise60.395,948359,200103,041Oct 26 05:04 PM
Fussell Stephen RSenior Vice PresidentOct 24Sale66.007,948524,56895,093Oct 26 05:04 PM
ALBAN CARLOSSenior Vice PresidentSep 25Option Exercise57.251,19868,586116,015Sep 27 05:10 PM
ALBAN CARLOSSenior Vice PresidentSep 25Sale70.001,19883,860114,817Sep 27 05:10 PM
FREYMAN THOMAS CExecutive Vice PresidentSep 21Option Exercise44.1630,0001,324,800438,086Sep 25 05:05 PM
ALBAN CARLOSSenior Vice PresidentSep 20Option Exercise56.981,918109,288116,735Sep 21 05:09 PM
ALBAN CARLOSSenior Vice PresidentSep 20Sale69.751,918133,781114,817Sep 21 05:09 PM
LINDER GREG WVice PresidentSep 14Option Exercise54.741,839100,667131,902Sep 17 05:04 PM
Warmuth Michael JSenior Vice PresidentSep 13Option Exercise54.053,368182,04047,993Sep 17 05:05 PM
ALBAN CARLOSSenior Vice PresidentSep 13Option Exercise56.001,33174,536116,148Sep 17 05:06 PM
ALBAN CARLOSSenior Vice PresidentSep 13Sale68.751,33191,506114,817Sep 17 05:06 PM
Landgraf John CExecutive Vice PresidentSep 07Option Exercise53.1838,5652,050,778132,777Sep 11 05:13 PM
Landgraf John CExecutive Vice PresidentAug 31Option Exercise49.13140,2586,891,194231,403Sep 05 05:16 PM
Landgraf John CExecutive Vice PresidentAug 31Sale65.50130,9448,576,83294,212Sep 05 05:16 PM
Warmuth Michael JSenior Vice PresidentAug 16Option Exercise44.169,400415,10454,025Aug 17 05:10 PM
Warmuth Michael JSenior Vice PresidentAug 16Sale66.479,400624,85444,625Aug 17 05:10 PM
Mason Heather LSenior Vice PresidentAug 01Option Exercise47.1396,3094,538,584228,121Aug 03 05:12 PM
Mason Heather LSenior Vice PresidentAug 01Sale66.328,700576,979124,312Aug 03 05:11 PM
Mason Heather LSenior Vice PresidentAug 01Sale66.2649,7963,299,638133,012Aug 03 05:12 PM
Mason Heather LSenior Vice PresidentAug 01Sale66.1945,3132,999,371182,808Aug 03 05:12 PM
Warmuth Michael JSenior Vice PresidentJul 30Option Exercise52.236,274327,69150,029Aug 01 05:28 PM
LINDER GREG WVice PresidentJul 30Option Exercise52.5320,5561,079,884148,106Aug 01 05:27 PM
Schumacher Laura JExecutive Vice PresidentJul 30Option Exercise52.744,560240,494152,594Aug 01 05:26 PM
Fussell Stephen RSenior Vice PresidentJul 30Option Exercise53.0010,988582,364106,783Aug 01 05:24 PM
ALBAN CARLOSSenior Vice PresidentJul 27Option Exercise43.1144,8371,933,087160,006Jul 30 05:05 PM
ALBAN CARLOSSenior Vice PresidentJul 27Sale65.0344,8372,915,943115,169Jul 30 05:05 PM
ALBAN CARLOSSenior Vice PresidentJul 23Option Exercise48.925,435265,858119,503Jul 25 05:39 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 23Option Exercise44.1630,0001,324,800432,443Jul 25 05:30 PM
Warmuth Michael JSenior Vice PresidentJul 23Option Exercise51.913,572185,42346,858Jul 25 05:08 PM
Fussell Stephen RSenior Vice PresidentJun 29Option Exercise50.952,275115,91198,070Jul 03 05:18 PM
Fussell Stephen RSenior Vice PresidentJun 29Sale64.422,275146,55895,795Jul 03 05:18 PM
open in yahoo | open in reuters | open in google